Shares of ConvaTec Group PLC (OTCMKTS:CNVVY – Get Free Report) rose 0.2% during trading on Monday . The company traded as high as $12.74 and last traded at $12.51. Approximately 64,086 shares were traded during trading, a decline of 44% from the average daily volume of 113,734 shares. The stock had previously closed at $12.49.
Analyst Ratings Changes
Separately, Sanford C. Bernstein upgraded ConvaTec Group to a “strong-buy” rating in a report on Wednesday, January 28th. Two investment analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat, ConvaTec Group presently has a consensus rating of “Strong Buy”.
Check Out Our Latest Stock Analysis on CNVVY
ConvaTec Group Stock Performance
ConvaTec Group Company Profile
ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.
Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.
Further Reading
- Five stocks we like better than ConvaTec Group
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
- Only 500 people today…
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.
